arginine has been researched along with Arterial Occlusive Diseases in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.13) | 18.7374 |
1990's | 28 (59.57) | 18.2507 |
2000's | 13 (27.66) | 29.6817 |
2010's | 5 (10.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatakeyama, M; Munakata, M; Ono, Y | 1 |
Al-Shaheen, A; Brittenden, J; Rajagopalan, S; Staniszewska, A; Thies, F | 1 |
Bek, S; Cakir, E; Gökçil, Z; Odabaşi, Z; Oz, O | 1 |
Accrocca, F; Antonelli, R; Gabrielli, R; Giordano, GA; Marcucci, G; Rosati, MS; Siani, A | 1 |
Asai, Y; Doi, M; Murawaki, A; Nakashima, K; Nakayasu, H; Omura, H; Suzuki-Kinoshita, K | 1 |
Balligand, JL | 1 |
Arakawa, N; Bode-Böger, SM; Böger, RH; Frölich, JC; Hornig, B; Schwedhelm, E; Sydow, K; Tsikas, D | 1 |
Ikoma, H | 1 |
Arakawa, N; Bode-Böger, SM; Böger, RH; Hornig, B; Münzel, T; Sydow, K; Tsikas, D | 1 |
Hofer, M; Krugluger, W; Krzyzanowska, K; Mittermayer, F; Schernthaner, G; Schnack, C; Wolzt, M | 1 |
Chen, CY; Cooley, BC; Schmeling, G | 1 |
Auteri, A; Blardi, P; Ceccatelli, L; De Franco, V; de Lalla, A; Meini, S; Pieragalli, D | 1 |
Boerkoel, CF; Clewing, JM; Das, AM; Ehrich, JH; Kanzelmeyer, NK; Lücke, T; Tsikas, D; Vaske, B | 1 |
Bozlar, U; Simsek, S; Turba, UC | 1 |
Adiloglu, AK; Akturk, O; Altuntas, I; Kapucuoğlu, N; Kiris, I; Okutan, H; Savas, C | 1 |
Bernardi, G; Iannone, M; Morello, M; Nisticò, G; Sancesario, G | 1 |
Frazzini, VI; Kader, A; Solomon, RA; Trifiletti, RR | 1 |
Hintze, TH; Stewart, JM; Wang, J | 1 |
de Novellis, V; Filippelli, A; Loffreda, A; Rossi, F | 1 |
Fujino, H; Ikeda, K; Kubota, A; Nara, Y; Numano, F; Tagami, M; Yamori, Y | 1 |
Griffith, TM; Randall, MD; Ujiie, H | 1 |
Ashwal, S; Cole, DJ; Osborne, TN; Pearce, WJ | 1 |
Ashwal, S; Cole, DJ; Osborne, S; Osborne, TN; Pearce, WJ | 1 |
Kawai, H; Nakashima, M; Umemura, K | 1 |
Casey, RM; Iadecola, C; Ross, ME; Zhang, F | 1 |
Alexander, K; Alfke, H; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Heinzel, D; Tsikas, D | 1 |
Bieroón, K; Goszcz, A; Grodzińska, L; Gryglewski, RJ; Korbut, R; Kostka-Trabka, E; Sławiński, M | 1 |
Dübbers, A; Nowak-Göttl, U; Oleszuk-Raschke, K; Sträter, R; Vielhaber, H | 1 |
Alexander, K; Bode-Böger, SM; Böger, RH; Frölich, JC; Junker, W; Thiele, W | 1 |
Bode-Böger, SM; Böger, RH | 1 |
Ishida, H; Nakayasu, H; Nukaya, H; Tsuji, K | 2 |
Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W | 1 |
Failla, A; Micci, A; Michelini, S; Moneta, G; Ottaviani, A | 1 |
Fukazawa, T; Goto, Y; Hayashi, H; Inoue, Y; Komatsu, Y | 1 |
Eguchi, K; Kizaki, Y; Matsumoto, K; Matsunaga, Y; Miyake, S; Tominaga, Y; Ueki, Y; Yano, M; Yoshida, K | 1 |
Ishida, H; Nakayasu, H; Tsuji, K | 1 |
Pepe, C; Rozza, A; Veronesi, G | 1 |
Herbaczyńska-Cedro, K | 1 |
Dalkara, T; Endres, M; Huang, PL; Huang, Z; Laufs, U; Liao, JK; Moskowitz, MA; Waeber, C; Yamada, M | 1 |
Hayakawa, M; Matsuzawa, M; Morishima, H; Ono, H; Oshima, K; Taguchi, Y | 1 |
Giddings, JC; Hashimoto, M; Oiwa, K; Watanabe, S; Yamamoto, J; Yamashita, T | 1 |
Griffith, TM; Randall, MD | 1 |
Clement, D; De Buyzere, M; Duprez, D; Van Wassenhove, A | 1 |
Bush, LR; Connolly, TM; Mellott, MJ; York, SJ | 1 |
Collen, D; Fallon, JT; Gold, HK; Jang, IK; Leinbach, RC; Ziskind, AA | 1 |
Abiko, Y; Hara, T; Iwamoto, M; Kumada, T; Ogawa, H; Tomikawa, M | 1 |
4 review(s) available for arginine and Arterial Occlusive Diseases
Article | Year |
---|---|
Development of argatroban as an anticoagulant and antithrombin agent in Japan.
Topics: Anticoagulants; Arginine; Arterial Occlusive Diseases; Humans; Intracranial Thrombosis; Japan; Pipecolic Acids; Product Surveillance, Postmarketing; Renal Dialysis; Sulfonamides; Thrombin | 2002 |
[Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use].
Topics: Arginine; Arterial Occlusive Diseases; Arteriosclerosis; Endothelium, Vascular; Humans; Nitric Oxide; Vasodilation | 1997 |
Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.
Topics: Arginine; Arterial Occlusive Diseases; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Heart Failure; Humans; Hyperlipidemias; Myocardial Ischemia; Nitric Oxide; Treatment Outcome | 1999 |
Incarceration of the basilar artery in a longitudinal fracture of the clivus: case report and literature review.
Topics: Antithrombins; Arginine; Arterial Occlusive Diseases; Basilar Artery; Cranial Fossa, Posterior; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pipecolic Acids; Respiration, Artificial; Skull Fractures; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
8 trial(s) available for arginine and Arterial Occlusive Diseases
Article | Year |
---|---|
ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Topics: Aged; Analysis of Variance; Arginine; Arterial Occlusive Diseases; Double-Blind Method; Female; Folic Acid; Humans; Hyperhomocysteinemia; Male; Middle Aged; Nitric Oxide Synthase; Oxidative Stress; Peripheral Vascular Diseases; Vitamin B 12; Vitamin B 6; Vitamins | 2003 |
Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Blood Platelets; Blood Pressure; Diabetes Mellitus, Type 2; Drug Administration Schedule; Exercise Test; Female; Humans; Iloprost; Infusions, Intravenous; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Serotonin; Treatment Outcome | 2006 |
L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study.
Topics: Aged; Arginine; Arterial Occlusive Diseases; Extremities; Humans; Injections, Intravenous; Ischemia; Male; Middle Aged; Nitric Oxide; Vasodilation | 1996 |
Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.
Topics: Adult; Aged; Arginine; Arterial Occlusive Diseases; Arteriosclerosis; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Exercise Test; Female; Fibrinolysis; Humans; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide; Platelet Aggregation; Vasodilator Agents | 1996 |
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Alprostadil; Arginine; Arterial Occlusive Diseases; Blood Flow Velocity; Chronic Disease; Cyclic GMP; Double-Blind Method; Exercise Test; Female; Femoral Artery; Follow-Up Studies; Humans; Infusions, Intravenous; Intermittent Claudication; Leg; Male; Middle Aged; Nitrates; Nitric Oxide; Peripheral Vascular Diseases; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilation; Vasodilator Agents | 1998 |
[Study on the efficacy of ginkgo biloba extract, magnesium and levo-arginine in the treatment of patients with 2d stage arteriopathies. A preliminary study].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Ginkgo biloba; Humans; Leg; Magnesium; Middle Aged; Plant Extracts; Plants, Medicinal; Platelet Aggregation Inhibitors | 1998 |
Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: placebo-controlled study.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Female; Hemoglobins; Humans; Infusions, Intravenous; Male; Microcirculation; Middle Aged; Nitric Oxide; Pipecolic Acids; Sulfonamides | 1999 |
[The evaluation by video capillaroscopy of the efficacy of a Ginkgo biloba extract with L-arginine and magnesium in the treatment of trophic lesions in patients with stage-IV chronic obliterating arteriopathy].
Topics: Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Chronic Disease; Drug Therapy, Combination; Female; Ginkgo biloba; Humans; Leg Ulcer; Magnesium; Male; Microscopic Angioscopy; Middle Aged; Phytotherapy; Plant Extracts; Plants, Medicinal; Video Recording | 1999 |
35 other study(ies) available for arginine and Arterial Occlusive Diseases
Article | Year |
---|---|
Thrombosis of biatrial appendages due to heparin-induced thrombocytopenia.
Topics: Aged, 80 and over; Antibodies; Anticoagulants; Arginine; Arterial Occlusive Diseases; Atrial Appendage; Atrial Fibrillation; Biomarkers; Coronary Artery Bypass; Drug Administration Schedule; Drug Substitution; Female; Heart Diseases; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombectomy; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed | 2013 |
Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease.
Topics: Aged; Ankle Brachial Index; Arginine; Arterial Occlusive Diseases; Biomarkers; Cause of Death; Female; Follow-Up Studies; Humans; Intermittent Claudication; Ischemia; Male; Middle Aged; Predictive Value of Tests | 2015 |
Is asymmetric dimethylarginine responsible for the vascular events in patients under antiepileptic drug treatment?
Topics: Adult; Anticonvulsants; Arginine; Arterial Occlusive Diseases; Carbamazepine; Drug Monitoring; Epilepsy; Female; Folic Acid; Homocysteine; Humans; Male; Statistics, Nonparametric; Valproic Acid; Vitamin B 12 | 2009 |
Heparin-induced thrombocytopenia type II because of heparin-coated polytetrafluoroethylene graft used to bypass.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Device Removal; Early Diagnosis; Female; Heparin; Humans; Lower Extremity; Pipecolic Acids; Polytetrafluoroethylene; Prosthesis Design; Reoperation; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2011 |
Heparin-induced thrombocytopenia in essential thrombocytosis.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Bone Marrow Examination; Cerebral Infarction; Constriction, Pathologic; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Femoral Artery; Heparin; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Predictive Value of Tests; Sulfonamides; Thrombocythemia, Essential; Thrombocytopenia; Thrombophlebitis; Treatment Outcome | 2012 |
Vitamin B or L-arginine supplementation in hyperhomocysteinaemia: think twice!
Topics: Arginine; Arterial Occlusive Diseases; Female; Humans; Hyperhomocysteinemia; Male; Vitamins | 2012 |
Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Chronic Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Nitric Oxide Synthase; Peripheral Vascular Diseases; Radial Artery; Ultrasonography; Vasodilation | 2004 |
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Topics: Aged; Arginine; Arterial Occlusive Diseases; Biomarkers; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Homocysteine; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Risk Factors; Severity of Illness Index | 2006 |
Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
Topics: Amino Acid Substitution; Animals; Arginine; Arterial Occlusive Diseases; Arteries; Chlorides; Disease Models, Animal; Factor V; Ferric Compounds; Gene Frequency; Glutamine; Homozygote; Mice; Mice, Inbred C57BL; Mutation; Thrombosis; Venous Thrombosis | 2007 |
Vaso-occlusion in Schimke-immuno-osseous dysplasia: is the NO pathway involved?
Topics: Adolescent; Adult; Arginine; Arterial Occlusive Diseases; Atherosclerosis; Child; Child, Preschool; Female; Glomerulosclerosis, Focal Segmental; Humans; Male; Nephrotic Syndrome; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Osteochondrodysplasias | 2006 |
Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Catheterization, Peripheral; Fibrinolytic Agents; Heparin; Humans; Infusions, Intra-Arterial; Lower Extremity; Male; Pipecolic Acids; Radiography; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome | 2007 |
The effect of Nomega-nitro-L-arginine methyl ester and L-arginine on lung injury induced by abdominal aortic occlusion-reperfusion.
Topics: Animals; Aorta, Abdominal; Arginine; Arterial Occlusive Diseases; Biomarkers; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Lung; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Reperfusion Injury; Respiratory Distress Syndrome; Spectrophotometry; Treatment Outcome; Vascular Endothelial Growth Factor A | 2008 |
Nitric oxide inhibition aggravates ischemic damage of hippocampal but not of NADPH neurons in gerbils.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Arterial Occlusive Diseases; Body Temperature; Carotid Artery Diseases; Drug Administration Schedule; Female; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; NAD; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Reperfusion; Stereoisomerism; Time Factors | 1994 |
Nitric oxide production during focal cerebral ischemia in rats.
Topics: Amino Acid Oxidoreductases; Analysis of Variance; Animals; Arginine; Arterial Occlusive Diseases; Brain; Cerebellum; Cerebral Arterial Diseases; Cerebral Cortex; Cyclic GMP; Functional Laterality; Ischemic Attack, Transient; Male; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Nitroarginine; Rats; Rats, Wistar | 1993 |
Role of EDRF in the regulation of shear rate in large coronary arteries in conscious dogs.
Topics: Adenosine; Animals; Arginine; Arterial Occlusive Diseases; Coronary Vessels; Dogs; Infusions, Intra-Arterial; Nitric Oxide; Nitroarginine; Stress, Mechanical; Vasodilation | 1994 |
Vasomotor reactivity and catecholamine, arginine vasopressin plasma levels during ageing and development in rats.
Topics: Acetylcholine; Aging; Animals; Arginine; Arterial Occlusive Diseases; Blood Pressure; Carotid Artery Diseases; Catecholamines; Hyperlipidemias; Hypertension; Isoproterenol; Norepinephrine; Rats; Rats, Inbred Strains; Vasomotor System; Vasopressins | 1994 |
Detailed examination of vascular lesions triggered by an inhibitor of endothelium-derived relaxing factor.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Blood Pressure; Blood Vessels; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Hydralazine; Hypertension, Renovascular; Incidence; Microscopy, Electron; Nitric Oxide; Nitroarginine; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium; Thrombosis; Time Factors; Vascular Diseases | 1995 |
L-arginine reverses the impairment of nitric oxide-dependent collateral perfusion in dietary-induced hypercholesterolaemia in the rabbit.
Topics: Acetylcholine; Animals; Arginine; Arterial Occlusive Diseases; Collateral Circulation; Disease Models, Animal; Endothelium, Vascular; Hypercholesterolemia; Muscle Relaxation; Muscle, Smooth, Vascular; Perfusion; Rabbits; Regional Blood Flow | 1994 |
Low dose L-NAME reduces infarct volume in the rat MCAO/reperfusion model.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Cerebrovascular Circulation; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Reperfusion | 1993 |
L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Cerebral Arteries; Cerebral Infarction; Disease Models, Animal; Ischemic Attack, Transient; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nylons; Rats; Rats, Inbred SHR | 1995 |
Effect of argatroban on microthrombi formation and brain damage in the rat middle cerebral artery thrombosis model.
Topics: Animals; Antithrombins; Arginine; Arterial Occlusive Diseases; Cerebral Arteries; Disease Models, Animal; Intracranial Embolism and Thrombosis; Male; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Thrombin; Time Factors | 1995 |
Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Base Sequence; Body Water; Brain; Brain Damage, Chronic; Cerebral Arterial Diseases; Cerebral Cortex; Cerebral Infarction; DNA Primers; Enzyme Induction; Enzyme Inhibitors; Guanidines; Ischemic Attack, Transient; Male; Molecular Sequence Data; Nitric Oxide Synthase; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1996 |
Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene.
Topics: Adolescent; Arginine; Arterial Occlusive Diseases; Brain Ischemia; Child; Child, Preschool; Enzyme Activation; Factor V; Female; Glutamine; Humans; Infant; Infant, Newborn; Male; Point Mutation; Prospective Studies; Protein C; Risk Factors; Thromboembolism | 1996 |
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Arterial Occlusive Diseases; Cyclic GMP; Disease Progression; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Peripheral Vascular Diseases; Vasodilation | 1997 |
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. II. Prophylactic effect of scymnol on lesion development in a rat peripheral arterial occlusion model.
Topics: Animals; Antithrombins; Arginine; Arterial Occlusive Diseases; Blood Coagulation; Cholestanols; Elasmobranchii; Fibrinolysis; Male; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Ticlopidine | 1998 |
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Topics: Amino Acid Sequence; Animals; Arginine; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Chlorides; Drug Evaluation, Preclinical; Ferric Compounds; Fibrinolytic Agents; Glass; Hemorrhage; Heparin; Hirudin Therapy; Hirudins; Molecular Sequence Data; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Serine Proteinase Inhibitors; Sulfonamides; Thrombin; Thrombosis; Vena Cava, Inferior; Venous Thrombosis | 1999 |
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. III. Protective effect of scymnol against vascular endothelial cell damage in a rat peripheral arterial occlusion model.
Topics: Alanine Transaminase; Animals; Antithrombin III; Arginine; Arterial Occlusive Diseases; Aspartate Aminotransferases; Bile Acids and Salts; Cells, Cultured; Cholestanols; Elasmobranchii; Endothelium, Vascular; L-Lactate Dehydrogenase; Male; Peripheral Vascular Diseases; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Ticlopidine | 1999 |
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. IV. Effects of naturally occurring bile alcohols, bile acids and their conjugates on lesion development and vascular endothelial cell injury in a rat
Topics: Animals; Arginine; Arterial Occlusive Diseases; Bile Acids and Salts; Cholestanols; Elasmobranchii; Endothelium, Vascular; Isoenzymes; L-Lactate Dehydrogenase; Male; Peripheral Vascular Diseases; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides | 1999 |
Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Cerebral Arteries; Cerebrovascular Circulation; Drug Synergism; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred Strains; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Simvastatin; Time Factors | 2000 |
Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Arterioles; Binding, Competitive; Carboxypeptidase B2; Enzyme Activation; Enzyme Inhibitors; Fibrinolysis; Fibrinolytic Agents; Image Processing, Computer-Assisted; Lasers; Male; Mesenteric Arteries; Models, Animal; Pipecolic Acids; Plant Proteins; Plasminogen Activators; Protease Inhibitors; Protein C; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Swine; Thrombosis | 2002 |
Effects of BRL 38227, sodium nitroprusside and verapamil on collateral perfusion following acute arterial occlusion in the rabbit isolated ear.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Benzopyrans; Cromakalim; Ear, External; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Pyrroles; Rabbits; Regional Blood Flow; Vasodilation; Vasodilator Agents; Verapamil | 1992 |
Evaluation of the metabolic compensation after treadmill test in patients with peripheral occlusive arterial disease.
Topics: Arginine; Arterial Occlusive Diseases; Blood Pressure; Energy Metabolism; Exercise Test; Female; Humans; Hypoxanthine; Hypoxanthines; Lactates; Male; Middle Aged; Peripheral Vascular Diseases; Time Factors | 1992 |
Prevention of reocclusion by MCI-9038, a thrombin inhibitor, following t-PA-induced thrombolysis in a canine model of femoral arterial thrombosis.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Disease Models, Animal; Dogs; Femoral Artery; Hemodynamics; Male; Pipecolic Acids; Recurrence; Regional Blood Flow; Sulfonamides; Thrombin; Thrombin Time; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1990 |
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
Topics: Animals; Antithrombins; Arginine; Arterial Occlusive Diseases; Bleeding Time; Blood Platelets; Femoral Artery; Graft Occlusion, Vascular; Heparin; In Vitro Techniques; Injections, Intra-Arterial; Injections, Intravenous; Pipecolic Acids; Rabbits; Regional Blood Flow; Sulfonamides; Thrombosis | 1990 |
[Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models].
Topics: Acute Disease; Animals; Antithrombin III Deficiency; Antithrombins; Arginine; Arterial Occlusive Diseases; Mice; Pipecolic Acids; Pulmonary Embolism; Rats; Rats, Inbred Strains; Sulfonamides; Thrombosis; Vena Cava, Inferior | 1987 |